PL3013363T3 - Szczepionka przeciwko dyzenterii świń - Google Patents

Szczepionka przeciwko dyzenterii świń

Info

Publication number
PL3013363T3
PL3013363T3 PL14734127T PL14734127T PL3013363T3 PL 3013363 T3 PL3013363 T3 PL 3013363T3 PL 14734127 T PL14734127 T PL 14734127T PL 14734127 T PL14734127 T PL 14734127T PL 3013363 T3 PL3013363 T3 PL 3013363T3
Authority
PL
Poland
Prior art keywords
swine dysentery
dysentery vaccine
vaccine
swine
dysentery
Prior art date
Application number
PL14734127T
Other languages
English (en)
Inventor
Pedro Miguel Rubio Nistal
Ana María Carvajal Ureña
Marta GARCÍA DÍEZ
Original Assignee
Aquilón Cyl S.L.
Universidad De León
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aquilón Cyl S.L., Universidad De León filed Critical Aquilón Cyl S.L.
Publication of PL3013363T3 publication Critical patent/PL3013363T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0225—Spirochetes, e.g. Treponema, Leptospira, Borrelia
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/116—Polyvalent bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PL14734127T 2013-06-28 2014-06-27 Szczepionka przeciwko dyzenterii świń PL3013363T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP13382255 2013-06-28
EP14734127.5A EP3013363B9 (en) 2013-06-28 2014-06-27 Swine dysentery vaccine
PCT/EP2014/063695 WO2014207202A1 (en) 2013-06-28 2014-06-27 Swine dysentery vaccine

Publications (1)

Publication Number Publication Date
PL3013363T3 true PL3013363T3 (pl) 2021-04-06

Family

ID=48703385

Family Applications (1)

Application Number Title Priority Date Filing Date
PL14734127T PL3013363T3 (pl) 2013-06-28 2014-06-27 Szczepionka przeciwko dyzenterii świń

Country Status (10)

Country Link
US (1) US9855322B2 (pl)
EP (1) EP3013363B9 (pl)
CN (1) CN105611941B (pl)
AU (1) AU2014300951B2 (pl)
BR (1) BR112015032468B1 (pl)
DK (1) DK3013363T3 (pl)
ES (1) ES2828873T3 (pl)
PL (1) PL3013363T3 (pl)
RU (1) RU2692647C2 (pl)
WO (1) WO2014207202A1 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10188715B2 (en) 2013-06-28 2019-01-29 Aquilon Cyl Sociedad Limitada Swine dysentery vaccine
EP3700559A1 (en) 2017-10-24 2020-09-02 Aquilón Cyl S.L. Single strain dysentery vaccine
EP4271405A1 (en) 2020-12-29 2023-11-08 Hipra Scientific, S.L.U. Immunogenic and vaccine compositions against swine dysentery

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4100272A (en) 1977-05-31 1978-07-11 Iowa State University Research Foundation, Inc. Method of increasing the resistance of swine to swine dysentery infection
US5554372A (en) * 1986-09-22 1996-09-10 Emory University Methods and vaccines comprising surface-active copolymers
US5236708A (en) * 1989-11-03 1993-08-17 Iowa State University Research Foundation, Inc. Reduced-protein subunit vaccine for swine dysentery
FR2707168B1 (fr) 1993-07-08 1995-08-18 Rhone Merieux Vaccin contre la dysenterie hémorragique du porc et ensemble de vaccination y relatif.
US7851212B2 (en) * 2000-05-10 2010-12-14 Sanofi Pasteur Limited Immunogenic polypeptides encoded by MAGE minigenes and uses thereof
RU2440369C2 (ru) * 2007-08-03 2012-01-20 Бёрингер Ингельхайм Ветмедика Гмбх ГЕНЫ И БЕЛКИ Brachyspira hyodysenteriae И ИХ ПРИМЕНЕНИЕ
KR20110092306A (ko) * 2008-11-14 2011-08-17 베링거 인겔하임 베트메디카 게엠베하 브라키스피라 하이오디센테리애의 백신 균주
US8057805B1 (en) * 2010-07-29 2011-11-15 Schweitzer Biotech Company Ltd. Edwardsiella ictaluri E-ict-VL33 strain, vaccines thereof, and a method for protecting fishes using said vaccines

Also Published As

Publication number Publication date
RU2016102767A (ru) 2017-08-03
EP3013363A1 (en) 2016-05-04
AU2014300951A1 (en) 2016-01-21
US20160184418A1 (en) 2016-06-30
CN105611941B (zh) 2019-12-10
RU2692647C2 (ru) 2019-06-25
EP3013363B9 (en) 2021-04-14
BR112015032468B1 (pt) 2023-03-07
ES2828873T3 (es) 2021-05-27
BR112015032468A2 (pt) 2018-01-23
EP3013363B1 (en) 2020-07-15
WO2014207202A1 (en) 2014-12-31
US9855322B2 (en) 2018-01-02
CN105611941A (zh) 2016-05-25
DK3013363T3 (da) 2020-10-19
AU2014300951B2 (en) 2019-05-16

Similar Documents

Publication Publication Date Title
IL276210B1 (en) Mers-cov vaccine
IL279395A (en) A vaccine
IL244816B (en) Protein-polymer-drug conjugates
IL245009A0 (en) Attach a drug from a protein and a polymer
GB201319791D0 (en) Formulations
ZA201508642B (en) Malaria vaccine
SG11201605260VA (en) Var2csa-drug conjugates
GB201315946D0 (en) Oncology vaccine
GB201318084D0 (en) Malaria vaccination
GB201321384D0 (en) Molecular adjuvant
PL2968493T3 (pl) Ulepszone szczepionki pokswirusowe
GB201301085D0 (en) Glycoconjugate Vaccine
GB201319792D0 (en) Formulations
IL245420B (en) New formulations
PL2944730T3 (pl) Miska ustępowa sedesu
GB201320432D0 (en) Novel formulation
PL2958935T3 (pl) Szczepionka
GB201322948D0 (en) Improved formulation
GB201317718D0 (en) Novel formulation
GB2547494B (en) Monovalent H5 vaccine
PL2991675T3 (pl) Szczepionka Campylobacter
GB201320646D0 (en) Vaccine
GB201315556D0 (en) Vaccine
GB201320421D0 (en) Conjugated vaccine
GB201319812D0 (en) Lavark variations